Status:
NOT_YET_RECRUITING
Epinephrine Vs Norepinephrine Infusion During Caesarean Delivery
Lead Sponsor:
Cairo University
Conditions:
Hypotension
Spinal Block
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Epinephrine is a well-known vasoactive agent in medical practice. However, its use is obstetric population is still scanty. Few studies evaluated the use of epinephrine during Cesarean delivery and a ...
Detailed Description
Upon arrival to the operating room, routine monitoring will be applied (electrocardiography, pulse oximetry, and non-invasive blood pressure monitor). An 18G-cannula will be inserted, and 10 mg metocl...
Eligibility Criteria
Inclusion
- full-term singleton pregnant women, admitted for elective cesarean delivery
Exclusion
- Patients with uncontrolled cardiac morbidities (patients with tight valvular lesion, impaired contractility with ejection fraction \< 50%, heart block, and arrhythmias),
- hypertensive disorders of pregnancy,
- peripartum bleeding,
- coagulation disorders (patients with INR \>1.4 and or platelet count \< 80000 /dL) or any contraindication to regional anesthesia,
- baseline systolic blood pressure (SBP) \< 100 mmHg
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT06512402
Start Date
August 1 2024
End Date
December 1 2024
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt